Evidence map›Paper›PMID 33297803›Full record

ReviewToxicology mechanisms and methods2021

Phosgene oxime: a highly toxic urticant and emerging chemical threat.

Satyendra K Singh, Joshua A Klein, Holly N Wright, Neera Tewari-Singh

Open access · greenAbstract readReview
In one paragraph

Review in Toxicology mechanisms and methods, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Satyendra K SinghDepartment of Pharmacology and Toxicology, Michigan State University, East Lansing, MI, USA.
Joshua A KleinDepartment of Pharmacology and Toxicology, Michigan State University, East Lansing, MI, USA.
Holly N WrightDepartment of Pharmacology and Toxicology, Michigan State University, East Lansing, MI, USA.
Neera Tewari-SinghDepartment of Pharmacology and Toxicology, Michigan State University, East Lansing, MI, USA.
Michigan State University · US

Funding

Targeted Therapeutic Approaches to Counteract Toxicity from Phosgene Oxime Skin ExposureU01AR075470 · NIAMS · MICHIGAN STATE UNIVERSITY · PI TEWARI-SINGH, NEERA · 2019 to 2021
$1.4M
Phosgene Oxime Cutaneous Toxicity and Mechanisms to Identify Therapeutic TargetsR21AR073544 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI TEWARI-SINGH, NEERA · 2017 to 2018
$487k
NIAMS NIH HHS R21 AR073544NIAMS NIH HHS U01 AR075470
6 · The paper itself

Abstract

Highly toxic industrial chemicals that are widely accessible, and hazardous chemicals like phosgene oxime (CX) that can be easily synthesized, pose a serious threat as potential chemical weapons. In addition, their accidental release can lead to chemical emergencies and mass casualties. CX, an urticant, or nettle agent, grouped with vesicating agents, causes instant pain, injury and systemic effects, which can lead to mortality. With faster cutaneous penetration, corrosive properties, and more potent toxicity compared to other vesicating agents, CX causes instantaneous and severe tissue damage. CX, a potential chemical terrorism threat agent, could therefore be weaponized with other chemical warfare agents to enhance their harmful effects. CX is the least studied vesicant and its acute and long-term toxic effects as well as its mechanism of action are largely unknown. This has hampered the identification of therapeutic targets and the development of effective medical countermeasures. There are only protective measures, decontamination, and supportive treatments available for reducing the toxic effects from CX exposure. This review summarizes CX toxicity, its known mechanism of action, and our current studies exploring the role of mast cell activation and associated signaling pathways in CX cutaneous exposure under the National Institutes of Health Countermeasures Against Chemical Threats program. Potential treatment options and the development of effective targeted countermeasures against CX-induced morbidity and mortality is also discussed.

Indexed as

Chemical Warfare AgentsIrritantsOximesPhosgeneSkinChemical Warfare AgentsIrritantsOximesPhosgeneinflammationmast cellsmedical countermeasuresmolecular mechanismsPhosgene oximetoxicityurticantvesicating agent

Identifiers

PMID33297803
PMCPMC8087642
OpenAlexW3112615707

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.